The Cannabis Regulatory Agency has released its May 2025 Disciplinary Action Report, detailing administrative formal complaints and disciplinary actions against various adult-use and medical cannabis licensees across the state. Read More »

Marion Mass, a pediatrician and co-founder of Free2Care, has raised concerns about the misuse of the 340B Drug Pricing Program by large healthcare corporations. Read More »

PCCA, a supplier of pharmaceutical ingredients, has achieved a milestone by becoming the first FDA-registered supplier to have its compounding bases verified by the U.S. Pharmacopeia (USP). Read More »

Shaun Noorian, founder and CEO of Empower Pharmacy, said that the rise of personalized medicine and national pharmacy networks is driving renewed demand for pharmaceutical compounding. Read More »

Registration is now open for the National Community Pharmacists Association's (NCPA) 2025 Annual Convention, as well as the Pre-Convention Growth and Profitability Programs. Read More »

June marks National Pet Preparedness Month, and both the Brandywine Valley SPCA (BVSPCA) and DC Health are encouraging pet owners to prepare for emergencies. Dr. Ayanna Bennett, Director of DC Health, emphasized the importance of including pets in... Read More »

Any person who visited specific locations in Rapid City during certain times may have been exposed to measles, according to a recent public health notice. Read More »

DC Health has announced a significant change in the administration of its School Health Services Program (SHSP). Read More »

The National Community Pharmacists Association (NCPA) has announced several upcoming events aimed at supporting pharmacists and their teams. Read More »

The Department of Health has reported the first measles case in South Dakota. Read More »

The South Dakota Department of Agriculture and Natural Resources (DANR) and the Department of Health (DOH) have issued an air quality alert for the state. Read More »

David Balto, a former policy director at the Federal Trade Commission (FTC), has raised concerns about the 340B drug discount program, alleging that it is being manipulated by corporate hospital systems and large pharmacies to the detriment of... Read More »

Empower Clinic Services LLC, a compounding pharmacy based in Houston, has petitioned the U.S. Patent Trial and Appeal Board (PTAB) to invalidate Eli Lilly & Co. Read More »

Danea Horn, a researcher at the University of California, has indicated that physicians or their employer organizations might select patients requiring intensive pharmaceutical treatments to benefit from financial incentives under the 340B program. Read More »

The Michigan Department of Licensing and Regulatory Affairs (LARA) has introduced its inaugural podcast, "LARA Living Room," during the Mackinac Policy Conference. Read More »

The National Consumers League (NCL) has announced the results of a national Morning Consult poll, which reveals significant public support for comprehensive reforms to the 340B Drug Pricing Program. Read More »

Pfizer and Moderna are required to update their COVID-19 vaccine labels to include stronger warnings about potential heart damage, according to the U.S. Food and Drug Administration (FDA). Read More »

Americans are expressing a strong desire for increased accountability from pharmaceutical companies regarding vaccine safety, according to a recent poll. Read More »

The Georgia Board of Pharmacy has issued a safety alert regarding compromised drug products. Read More »

The National Community Pharmacists Association (NCPA) has expressed approval following the House of Representatives' passage of a budget reconciliation bill. Read More »